Serum creatinine =< . x upper limit of normal (ULN) or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Serum creatinine =< . x ULN or creatinine clearance (CrCl) >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used, within days before the first dose of cabozantinib
Serum creatinine =< . x ULN or creatinine clearance (CrCl) >= mL/min within days before the first dose of cabozantinib. For creatinine clearance estimation, the Cockcroft and Gault equation should be used
Creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation.
STUDY TREATMENT: Creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation within days prior to the first study treatment.
Obtained within days prior to the first dose of cabozantinib: serum creatinine =< . x ULN or creatinine clearance (CrCl) >= mL/min. For creatinine clearance estimation, the Cockcroft and Gault equation should be used.
Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft?Gault glomerular filtration rate estimation
Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation.
Serum creatinine =< . x ULN OR creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation, obtained within days prior to first study treatment
Within days before the first dose of study treatment: Serum creatinine =< . x the ULN or creatinine clearance (CrCl) >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Obtained within days prior to the first study treatment (cycle , day ): serum creatinine =< . x ULN or creatinine clearance =< mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Within days prior to registration: Serum creatinine =< . x ULN or creatinine clearance (CrCl) >= mL/min on the basis of measured CrCl from a -hour urine collection or Cockcroft-Gault glomerular filtration rate estimation
Within days prior to the first study treatment (cycle , day ): Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Serum creatinine ?. x ULN or creatinine clearance ? mL/min based on either urine collection or Cockcroft Gault estimation.
Serum creatinine ? . x ULN or creatinine clearance ? mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation within days prior to the first study treatment (cycle , day )
Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Within days prior to the first dose of cabozantinib: Serum creatinine =< . x ULN or creatinine clearance (CrCl) >= mL/min (for creatinine clearance estimation, the Cockcroft and Gault equation should be used)
Serum creatinine =< . x ULN OR creatinine clearance (CrCl) >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Serum creatinine =< . x ULN or creatinine clearance (CrCl) >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Within days prior to the first study treatment (cycle , day ): Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation.
Creatinine ? x ULN OR creatinine clearance > mL/min based on the Cockroft-Gault glomerular filtration rate (GFR) estimation within days prior to registration
RENAL COHORT: Laboratory values as follows within days before the first dose of daratumumab: serum creatinine clearance (CrCl) ? mL/min; dialysis patients will be excluded; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
BLADDER: Clinical laboratory values at screening: serum creatinine clearance (CrCl) ? mL/min; dialysis patients will be excluded; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Within days before the first dose of cabozantinib: Serum creatinine =< . x ULN or creatinine clearance (CrCl) >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Serum creatinine =< . x ULN or creatinine clearance (CrCl) >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Creatinine clearance (CrCl) >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Serum creatinine ? . x ULN or creatinine clearance ? mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation:
Creatinine clearance > mL/min (assessed by Cockcroft Gault estimation)
Within days prior to the first study treatment (cycle , day ): Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Creatinine clearance > mL/min (assessed by Cockcroft Gault estimation)
Obtained within days prior to the first study treatment (cycle , day ); serum creatinine ? . x ULN or creatinine clearance ? mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Serum creatinine =< . X ULN or creatinine clearance >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Serum creatinine =< . x ULN or creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation (obtained within days prior to the first study treatment [course , day ])
Alkaline phosphatase . ULN with the following exception: Patients with liver or bone inv ULN or creatinine clearance mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation: ( age) (weight in kg) (. if female) (serum creatinine in mg/dL)
Serum creatinine =< . x ULN OR creatinine clearance >= mL/min/. m^ by Cockcroft-Gault estimation
Within days prior to first study treatment: Serum creatinine =< . x ULN OR creatinine clearance >= mL/min on the basis of the Cockcroft-Gault glomerular filtration rate estimation
Serum creatinine =< . x ULN or creatinine clearance (CrCl) >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Serum creatinine =< . x ULN, or creatinine clearance (CrCl) >= mL/min; for creatinine clearance estimation, the Cockcroft and Gault equation should be used
Measured or calculated creatinine clearance >= milliliters per minute (mL/min) on the basis of the Cockcroft-Gault glomerular filtration rate estimation Cancer-Specific Inclusion Criteria:
Creatinine clearance > mL/min (assessed by Cockcroft Gault estimation) and creatinine < . x ULN
Creatinine clearance >= mL/min (assessed by Cockcroft Gault estimation)